BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 19577961)

  • 1. Biomarkers of premature atherosclerosis.
    Kampoli AM; Tousoulis D; Antoniades C; Siasos G; Stefanadis C
    Trends Mol Med; 2009 Jul; 15(7):323-32. PubMed ID: 19577961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein in atherosclerosis: A causal factor?
    Paffen E; DeMaat MP
    Cardiovasc Res; 2006 Jul; 71(1):30-9. PubMed ID: 16624260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
    Rao M; Jaber BL; Balakrishnan VS
    Semin Dial; 2006; 19(2):129-35. PubMed ID: 16551290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRP--a marker of a pro-inflammatory state and cardiovascular risk].
    Poledne R; Valenta Z; Pit'ha J
    Vnitr Lek; 2007 Apr; 53(4):391-5. PubMed ID: 17578172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
    Yosef-Levi IM; Grad E; Danenberg HD
    Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers in stable atherosclerosis.
    Kinlay S; Egido J
    Am J Cardiol; 2006 Dec; 98(11A):2P-8P. PubMed ID: 17126676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein comes of age.
    Verma S; Szmitko PE; Ridker PM
    Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):29-36; quiz 58. PubMed ID: 16265340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to identify patients with vulnerable plaques.
    Virani SS; Ballantyne CM
    Diabetes Obes Metab; 2008 Sep; 10(10):824-33. PubMed ID: 17970757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of C-reactive protein and other acute phase markers in atherosclerosis].
    Gusev DE; Ponomar' EG
    Klin Med (Mosk); 2006; 84(5):25-30. PubMed ID: 16827274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 12. How to identify the asymptomatic high-risk patient?
    Schuijf JD; Achenbach S; Zoghbi WA; Boersma E; Raggi P; Weber M; Nagel E; Narula J; Wackers FJ; Poldermans D; Bax JJ
    Curr Probl Cardiol; 2009 Nov; 34(11):539-77. PubMed ID: 19804855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis in ANCA-associated vasculitides.
    Pagnoux C; Chironi G; Simon A; Guillevin L
    Ann N Y Acad Sci; 2007 Jun; 1107():11-21. PubMed ID: 17804528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation.
    Ferri N; Paoletti R; Corsini A
    Curr Opin Lipidol; 2006 Oct; 17(5):495-501. PubMed ID: 16960497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory and long-term risk markers.
    Levinson SS
    Clin Lab Med; 2006 Sep; 26(3):553-70, v. PubMed ID: 16938584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRP--marker or maker of cardiovascular disease?
    Nilsson J
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1527-8. PubMed ID: 16055753
    [No Abstract]   [Full Text] [Related]  

  • 20. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part I].
    Rajtar R; Kloch M; Bober M; KolasiƄska-Kloch W
    Przegl Lek; 2006; 63(9):762-6. PubMed ID: 17479866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.